Clinical trial
Umbilical Cord Derived Mesenchymal Stem Cell (UC-MSC) Transplantation in Infants with Biliary Atresia: a Prospective Randomized Controlled Trial
NCT06564740 is registered in ClinicalTrials.gov with Necmi Kadıoğlu Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Derived Mesenchymal Stem Cell (UC-MSC) Transplantation in Infants with Biliary Atresia: a Prospective Randomized Controlled Trial
- Lead sponsor
- Necmi Kadıoğlu Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2024
- Completion date
- June 1, 2026
- Enrollment
- 64 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biliary atresia, fibrosis, liver, stem cell